TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Biomentek AS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
36,535
|
23,550
|
15,113 |
Financial expenses |
69
|
146
|
101 |
Earnings before taxes |
2,330
|
1,115
|
285 |
Total assets |
11,414
|
7,595
|
5,778 |
Current assets |
9,099
|
6,378
|
4,505 |
Current liabilities |
6,022
|
4,002
|
3,189 |
Equity capital |
4,774
|
3,327
|
2,272 |
- share capital |
745
|
723
|
673 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
41.8%
|
43.8%
|
39.3% |
Turnover per employee | |||
Profit as a percentage of turnover |
6.4%
|
4.7%
|
1.9% |
Return on assets (ROA) |
21.0%
|
16.6%
|
6.7% |
Current ratio |
151.1%
|
159.4%
|
141.3% |
Return on equity (ROE) |
48.8%
|
33.5%
|
12.5% |
Change turnover |
12,256
|
7,315
|
1,562 |
Change turnover % |
50%
|
45%
|
12% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.